跳至主要内容
临床试验/NCT05937698
NCT05937698终止不适用

The CATALYST Study: Catalyzing Access to New Prevention Products to Stop HIV

FHI 36028 个研究点 分布在 5 个国家目标入组 6,069 人开始时间: 2023年5月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
FHI 360
入组人数
6,069
试验地点
28
主要终点
Patterns of PrEP use

研究概览

简要总结

The CATALYST study is an implementation study that will characterize and assess the implementation of an enhanced service delivery package providing informed choice of pre-exposure prophylaxis (PrEP) products among women at PEPFAR sites in Kenya, Lesotho, South Africa, Uganda, and Zimbabwe.

详细描述

The overall study goal is to characterize and assess the implementation of an enhanced service delivery package providing informed choice of pre-exposure prophylaxis (PrEP) products among women at U.S. President's Plan for AIDS Relief/U.S. Agency for International Development (PEPFAR/USAID) delivery sites in Kenya, Lesotho, South Africa, Uganda, and Zimbabwe. The study will be conducted in two stages, with currently approved oral PrEP and PrEP rings offered in Stage I, and the addition of CAB PrEP in Stage II after it has been approved by the regulatory authority in each country. The study goal will be accomplished by conducting a mixed-methods implementation study involving several components:

  1. Component 1: Prospective cohort study of women at PEPFAR/USAID delivery sites that are delivering HIV PrEP, including daily oral PrEP, monthly PrEP rings, and bimonthly CAB PrEP

  2. Descriptive nested cohort study to evaluate the performance characteristics of different HIV testing strategies among participants who initiate CAB PrEP

  3. Descriptive nested cohort study to evaluate the feasibility and validity of a prevention effective use (PEU) measure among a subset of PrEP users

  4. Component 2: Mixed-methods process evaluation involving implementers and key stakeholders

  5. Nested costing study across Lesotho, Uganda, and Zimbabwe study sites

  6. Nested qualitative study to understand community acceptance of PrEP and informed choice of PrEP products

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Tested HIV-negative as determined by the national HIV testing algorithm at a CATALYST site on the same day as enrollment
  • Self-identify with at least one of the following populations:
  • Adolescent girl or young women (AGYW) ages 15-24 years
  • Female sex worker (FSW) ages 18 years and older
  • Pregnant and breastfeeding populations (PBFP) ages 15 years and older
  • Individuals assigned female at birth of any gender identity ages 15 years and older
  • Individuals assigned male at birth who identify as women ages 15 years and older
  • Other women ages 25 years and older
  • Interested in learning about HIV prevention
  • Willing to be contacted for follow-up by phone or other means (e.g., through a community health worker)
  • Willing and able to provide informed written consent for participation

排除标准

  • For participants ages 15-17 years, potential participants under the age of 18 may be excluded from study participation based on country guidelines and the age of consent. This determination will vary by country, including countries' definitions of emancipated minors. Country-specific informed consent forms will outline the country-specific inclusion criteria related to age.
  • Certain sub-categories of participants may be excluded based on country guidelines.

结局指标

主要结局

Patterns of PrEP use

时间窗: 24 months

Person-time of continued use of a certain PrEP method, until switching to another method or missed resupply; Person-time of pause between missed resupply and reinitiation or switching (subset).

Overall and method-specific PrEP method uptake

时间窗: 24 months

Proportion of cohort members who initiate oral PrEP, the PrEP ring, CAB PrEP, or decline all PrEP or are ineligible for PrEP

Qualitative assessment of health system feasibility

时间窗: 24 months

The extent to which PrEP choice and the enhanced service delivery package can be successfully carried out at facilities within health systems involved in CATALYST. This measure will be assessed through qualitative data collected through periodic in-depth interviews conducted among PrEP providers, community stakeholders, and key informants at selected sites.

Delivery acceptability among providers measured using an adapted version of the Acceptability of Intervention Measure (AIM)

时间窗: 24 months

Perception that offering informed choice of PrEP products and the provision of the enhanced service delivery package are agreeable or satisfactory in this setting as measured though an adapted version of the acceptability of intervention measure (Weiner et al. 2017), a 5-item scale with higher scores representing greater acceptability (range: 5-25).

次要结局

未报告次要终点

研究者

发起方
FHI 360
申办方类型
Other
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验